Advantage Medicals (UK) Limited |
Registered number: |
08041241 |
Balance Sheet |
as at 30 April 2023 |
|
Notes |
|
|
2023 |
|
|
2022 |
£ |
£ |
Fixed assets |
Tangible assets |
3 |
|
|
- |
|
|
3,249 |
|
Current assets |
Debtors |
4 |
|
6,483 |
|
|
21,900 |
Cash at bank and in hand |
|
|
114,369 |
|
|
115,344 |
|
|
|
120,852 |
|
|
137,244 |
|
Creditors: amounts falling due within one year |
5 |
|
(4,999) |
|
|
6,019 |
|
Net current assets |
|
|
|
115,853 |
|
|
143,263 |
|
Net assets |
|
|
|
115,853 |
|
|
146,512 |
|
|
|
|
|
|
|
|
Capital and reserves |
Called up share capital |
|
|
|
100 |
|
|
100 |
Profit and loss account |
|
|
|
115,753 |
|
|
146,412 |
|
Shareholders' funds |
|
|
|
115,853 |
|
|
146,512 |
|
|
|
|
|
|
|
|
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
The members have not required the company to obtain an audit in accordance with section 476 of the Act. |
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
|
|
|
Mustafa OSOY |
Director |
Approved by the board on 11 July 2023 |
|
Advantage Medicals (UK) Limited |
Notes to the Accounts |
for the year ended 30 April 2023 |
|
|
1 |
Accounting policies |
|
|
Turnover |
|
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. |
|
|
Intangible fixed assets |
|
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses. |
|
|
Investments |
|
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account. |
|
|
Debtors |
|
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts. |
|
|
Creditors |
|
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. |
|
|
2 |
Employees |
2023 |
|
2022 |
Number |
Number |
|
|
Average number of persons employed by the company |
- |
|
- |
|
|
|
|
|
|
|
|
|
|
3 |
Tangible fixed assets |
|
|
|
|
Plant and machinery etc |
|
Motor vehicles |
|
Total |
£ |
£ |
£ |
|
Cost |
|
At 1 May 2022 |
6,637 |
|
13,263 |
|
19,900 |
|
Disposals |
- |
|
(1,416) |
|
(1,416) |
|
At 30 April 2023 |
6,637 |
|
11,847 |
|
18,484 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 1 May 2022 |
5,276 |
|
11,375 |
|
16,651 |
|
Charge for the year |
1,361 |
|
472 |
|
1,833 |
|
At 30 April 2023 |
6,637 |
|
11,847 |
|
18,484 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 30 April 2023 |
- |
|
- |
|
- |
|
At 30 April 2022 |
1,361 |
|
1,888 |
|
3,249 |
|
|
4 |
Debtors |
2023 |
|
2022 |
£ |
£ |
|
|
Other debtors |
6,483 |
|
21,900 |
|
|
|
|
|
|
|
|
|
|
5 |
Creditors: amounts falling due within one year |
2023 |
|
2022 |
£ |
£ |
|
|
Corporation tax |
- |
|
(6,478) |
|
Other taxes and social security costs |
- |
|
(20) |
|
Other creditors |
4,999 |
|
479 |
|
|
|
|
|
|
4,999 |
|
(6,019) |
|
|
|
|
|
|
|
|
|
|
6 |
Controlling party |
|
|
Mustafa OSOY, a company director controls the company by virtue of holding 100% of the issued share capital. |
|
|
7 |
Other information |
|
|
Advantage Medicals (UK) Limited is a private company limited by shares and incorporated in England. Its registered office is: |
|
14 Ensign Drive |
|
London |
|
N13 5AN |